Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses    
Research and development $ 1,184,880 $ 1,265,653
General and administrative 1,915,278 1,622,368
Total operating expenses 3,100,158 2,888,021
Operating loss (3,100,158) (2,888,021)
Other expense    
Change in fair value of derivative liability (3) (43,655)
Interest expense 18,399 199,033
Interest income (24,514) 0
Loss from divestiture of asset 307,086 0
Debt conversion inducement expense 1,383,285 0
Wind-down costs 383,109 0
Total other expense, net 2,067,362 155,378
Loss before income taxes (5,167,520) (3,043,399)
Net loss $ (5,167,520) $ (3,043,399)
Loss per common share:    
Basic (in dollars per share) $ (0.01) $ (0.01)
Diluted (in dollars per share) $ (0.01) $ (0.01)
Weighted average shares of common stock outstanding used to compute earnings per share:    
Basic (in shares) 941,894,609 495,823,445
Diluted (in shares) 941,894,609 495,823,445